Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(3.42)
# 976
Out of 4,983 analysts
387
Total ratings
42.16%
Success rate
5.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $21.27 | +135.07% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.59 | +234.26% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $461.14 | +23.61% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.14 | +678.21% | 17 | Aug 4, 2025 | |
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $4.65 | +222.58% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $3.77 | +165.25% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.28 | +290.63% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.50 | +1,898.80% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $4.57 | +1,542.94% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $34.31 | +191.46% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $14.84 | +371.86% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.24 | +303.23% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.50 | +1,233.33% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $28.67 | +179.04% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.08 | +205.81% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.21 | +612.59% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $32.50 | +115.38% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $21.28 | +275.94% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.97 | +407.61% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.18 | +214.47% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $9.55 | +475.92% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $4.79 | +2,196.45% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $48.66 | +74.68% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.01 | +2,395.84% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.88 | +390.09% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $193.49 | +75.72% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $21.27
Upside: +135.07%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.59
Upside: +234.26%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $461.14
Upside: +23.61%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.14
Upside: +678.21%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.65
Upside: +222.58%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $3.77
Upside: +165.25%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.28
Upside: +290.63%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.50
Upside: +1,898.80%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $4.57
Upside: +1,542.94%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $34.31
Upside: +191.46%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $14.84
Upside: +371.86%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.24
Upside: +303.23%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.50
Upside: +1,233.33%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $28.67
Upside: +179.04%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $13.08
Upside: +205.81%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.21
Upside: +612.59%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $32.50
Upside: +115.38%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $21.28
Upside: +275.94%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.97
Upside: +407.61%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.18
Upside: +214.47%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $9.55
Upside: +475.92%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $4.79
Upside: +2,196.45%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $48.66
Upside: +74.68%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.01
Upside: +2,395.84%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.88
Upside: +390.09%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $193.49
Upside: +75.72%